Renexin XR 500 mg (Tablet (Extended Release))
Unit Price: ৳ 16.00 (3 x 10: ৳ 480.00)
Strip Price: ৳ 160.00
Medicine Details
Category | Details |
---|---|
Generic | Ranolazine |
Company | Opsonin pharma ltd |
Title
- Renexin ER
Categories
- Medicine
- Pharmaceutical
Description
- Renexin ER is a medication indicated for the treatment of chronic angina. It may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. It has been shown to decrease angina episodes in patients with coronary artery disease.
Brand Name
Renexin ER
Indications
- Treatment of chronic angina
- Decrease in angina episodes
- Use with other antianginal drugs
Pharmacology
- Anti-ischemic effects
- Anti-anginal effects
- Inhibition of cardiac late sodium current
- Prolongation of QT interval
- Metabolism by CYP3A
- Metabolism in liver and intestine
Dosage & Administration
- Initiate at 500mg twice daily
- Maximum recommended daily dose of 1000mg twice daily
- Swallow whole, do not crush or chew
- Contraindicated in pediatric patients
Interactions
- Strong CYP 3A inhibitors
- Moderate CYP 3A inhibitors
- P-gp inhibitors
- Drugs transported by P-gp or metabolized by CYP2D6
Contraindications
- Pre-existing QT prolongation
- Hepatic impairment
- Taking QT prolonging drugs
- Taking potent CYP3A inhibitors
Side Effects
- Bradycardia
- Palpitations
- Tinnitus
- Vertigo
- Abdominal pain
- Dry mouth
- Dyspnea
- Hypotension
- Peripheral edema
Pregnancy & Lactation
- Pregnancy Category C
- No adequate studies in pregnant women
- Potential risk to the fetus
- Use during pregnancy justified by potential benefit
- Unknown excretion in human milk
- Consideration for nursing mothers
Precautions & Warnings
- Blocks QTc interval
- Prolongs QTc interval
- No increased risk of proarrhythmia or sudden death
- Co-administration with digoxin
- Caution with P-gp inhibitors
Overdose Effects
- Dose-related increases in dizziness, nausea, and vomiting
- Diplopia
- Paresthesia
- Continuous ECG monitoring may be warranted
- Hemodialysis unlikely to be effective
Therapeutic Class
- Other Anti-anginal & Anti-ischemic drugs
Storage Conditions
- Below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children
Related Brands
- Ralozine SR 500 mg (Tablet (Sustained Release)) - incepta-pharmaceuticals-ltd
- Ranolin XR 500 mg (Tablet (Extended Release)) - square-pharmaceuticals-plc
- Ranola 500 mg (Tablet (Extended Release)) - general-pharmaceuticals-ltd
- Ranozex 500 mg (Tablet (Extended Release)) - sun-pharmaceutical-bangladesh-ltd
- Antogin ER 500 mg (Tablet (Extended Release)) - renata-limited